Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963174 | Vaccine | 2015 | 6 Pages |
Abstract
Population-based data from the United States indicate significant reductions in CIN2+ lesions attributable to types targeted by the vaccines and increasing HPV vaccine effectiveness with increasing interval between first vaccination and earliest detection of cervical disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Susan Hariri, Nancy M. Bennett, Linda M. Niccolai, Sean Schafer, Ina U. Park, Karen C. Bloch, Elizabeth R. Unger, Erin Whitney, Pamela Julian, Mary W. Scahill, Nasreen Abdullah, Diane Levine, Michelle L. Johnson, Martin Steinau, Lauri E. Markowitz,